Showing 751-760 of 1119 results for "".
- Galderma Rolls Out Restylane Refyne, Defynehttps://modernaesthetics.com/news/galderma-rolls-out-restylane-refyne-defyne/2472262/With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --
- FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”https://modernaesthetics.com/news/fda-approves-restylane-refyne-and-restylane-defyne-dermal-fillers-for-laugh-lines/2472303/The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane®
- Sciton Launches Multi-Wavelength Resurfacing Laser Platformhttps://modernaesthetics.com/news/sciton-launches-multi-wavelength-resurfacing-laser-platform/2483427/Sciton, Inc. has introduced HALO® TRIBRID™, a laser platform that integrates 3 wavelengths—2940 nm, 1927 nm, and 1470 nm—into a single resurfacing device. The system combines the company’s previously distinct technologies (HALO®, MOXI™, and Erbium Resurfacing) into one handpiece, allowing provide
- Study Identifies Age-Related Collagen Changes in Vaginal Tissuehttps://modernaesthetics.com/news/study-identifies-age-related-collagen-changes-in-vaginal-tissue/2483214/A new study published in the Aesthetic Surgery Journal has identified key age-related changes in vaginal wall collagen that may contribute to the progressive degeneration of the female reproductive system. The study, titled “Age-Associated Collagen Remodeling in Vaginal Tissue: A
- Revance Brings Mepivacaine-Based Fillers to US Markethttps://modernaesthetics.com/news/revance-brings-mepivacaine-based-fillers-to-us-market/2483155/Revance has announced the US launch of the Teoxane RHA® Collection with Mepivacaine, marking a significant innovation in dermal filler formulations. The update reflects a shift in anesthetic agents used in hyaluronic acid fillers, with mepivacaine replacing lidocaine as the primary ane
- JUVÉDERM Day Returns with Limited-Time Offers Through Rewards Programhttps://modernaesthetics.com/news/juvederm-day-returns-limited-time-offers-through-rewards-program/2482957/Members of JUVÉDERM’s Alle loyalty rewards program will have an opportunity to purchase “buy one, get one” gift cards as part of JUVÉDERM Day on August 20, according to Allergan Aesthetics, an AbbVie company. Details of the exclusive, limited limited-time offers are as follows: •
- TOPICAL SKIN Launches Antioxidant Face Oilhttps://modernaesthetics.com/news/topical-skin-launches-antioxidant-face-oil/2476145/Skincare brand TOPICAL SKIN launched Phyto AOX Face Oil N°10, a plant-based facial oil developed to protect the skin from environmental damage such as pollution, UV rays, and blue light. The formula features a proprietary Exposome Defense Technology, describ
- Alma Introduces PixelPeel™ Laser Peel for Minimal-Downtime Skin Renewalhttps://modernaesthetics.com/news/alma-introduces-pixelpeel-laser-peel-for-minimal-downtime-skin-renewal/2476137/Alma has launched PixelPeel™, a new fractional laser peel treatment designed for subtle, controlled skin resurfacing with minimal recovery time. The treatment is compatible with the Alma Pixel™ and Alma Hybrid® platforms and uses the company’s MotionSync™ technology to deliver uniform exfoliation
- AMI Pharm Advances AYP-101 to Phase 3 Testing for Noninflammatory Fat Reductionhttps://modernaesthetics.com/news/ami-pharm-advances-ayp-101-to-phase-3-testing-for-noninflammatory-fat-reduction/2476093/AMI Pharm has initiated a pivotal Phase 3 clinical trial of AYP-101, an investigational injectable for the treatment of submental fat. The study will evaluate the efficacy and safety of the agent, which is designed to reduce localized fat with fewer inflammatory side effects than current therapie
- SkinCeuticals Introduces A.G.E. Interrupter Ultra Serum to Address Sagging Skinhttps://modernaesthetics.com/news/skinceuticals-introduces-age-interrupter-ultra-serum-to-address-sagging-skin/2476036/SkinCeuticals announced the launch of its A.G.E. Interrupter Ultra Serum, a new addition to its A.G.E. line designed to target skin laxity. Sagging skin, often heightened by factors such as rapid weight loss, has become a growing concern among patients seeking dermatologic care. This serum offers